Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Edvard Javrid"'
Autor:
Bertrand Coiffier, Dzhelil Osmanov, Mariana Vasilica, Won Seog Kim, Aliaksandr Prokharau, Sungyoung Lee, Juan-Manuel Sancho, Christian Buske, Jin Seok Kim, Sang-Joon Lee, Wojciech Jurczak, Edvard Javrid, Larry W. Kwak, Rajnish Nagarkar, Jose Angel Hernandez Rivas, Michinori Ogura, Yunju Bae
Publikováno v:
Journal of Clinical Oncology. 35:7532-7532
7532 Background: CT-P10 is a biosimilar candidate to the innovator rituximab (RTX). In patients with rheumatoid arthritis, CT-P10 has demonstrated equivalence in pharmacokinetics (PK) and efficacy (Yoo, ACR 2016). This study aimed to demonstrate non-
Autor:
Zakaria Zautashvili, V. Baryash, Rubi Khaw Li, Gabriela Morar-Bolba, Daniil Stroyakovskiy, Francisco J. Esteva, Dmitry Komov, Joanna Pikiel, Andriy Rusyn, Dmytro Boliukh, Igor Lifirenko, Alexey Manikhas, Vladimir Moiseyenko, Sang Joon Lee, Justin Stebbing, Sung Young Lee, Alexandru Eniu, Giorgi Dzagnidze, Edvard Javrid, Yauheni Valerievich Baranau
Publikováno v:
Journal of Clinical Oncology. 35:510-510
510 Background: CT-P6 (C) is a proposed biosimilar to trastuzumab. This trial (NCT02162667) evaluated the similarity of C and trastuzumab in efficacy and safety for HER2+ EBC. Methods: 549 patients with HER2+ EBC were randomized to receive C (n=271)
Publikováno v:
Journal of Clinical Oncology. 32:e20008-e20008
e20008 Background: Interleukin-2 (Biotech, Russia) is a complete structural and functional analogue of human endogenous interleukin-2 produced from nonpathogenic Saccharomyces cerevisiae. Our retro...